Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Noninvasive capilaroscopy, laser Doppler flowmetry, and retinal imaging among techniques used….
Read More »Reprogramming of Fibroblasts into Pancreatic-like Betacells
Faster way to reprogram fibroblasts to bypass pancreatic-pluripotent state shown in mouse models….
Read More »Decreasing Sedentary Time Reduces T2DM Risk
Self-reported television viewing may not be an accurate measure of total sedentary time….
Read More »Nasal Spray May Help Treat Gastroparesis
Possible circumvention for anti-nausea drug, metoclopramide, shows promise….
Read More »Diabetes during Puberty Increases Risk of Complications
Girls with diabetes are at an even greater risk for excessive weight gain during puberty….
Read More »Pen vs. Vial-and-Syringe: Which do Patients Prefer?
Early insulin treatment can help but many type 2 patients are still reluctant to start therapy….
Read More »Basal Bolus Insulin Treatment for Type 2 Diabetes
How effective is basal/bolus insulin treatment for type 2 diabetes?…
Read More »Early A1C Test Detects Diabetes Risk
A1c screening can reveal risk of type 2 before the disease begins to develop….
Read More »Consuming Cooked Meat Can Influence Renal Function Test Results
Potential of CKD misclassification due to increases in serum creatinine levels….
Read More »New SGLT-2 Class of Diabetes Drug May Have Paradoxical Effect
But SGLT-2 inhibitors still yield net reduction in plasma glucose, A1C, and weight…. A new class of drugs for type 2 diabetic patients known as sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the latest thing used to reduce plasma glucose levels in the body. The SLGT-2 protein is responsible for about …
Read More »